β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm0798-822 →Countries where authors are citing β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy
This map shows the geographic impact of β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy more than expected).
Fields of papers citing β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy
This network shows the impact of β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy.
About β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy
This paper, published in 1998, received 742 indexed citations . Written by Claudio Soto, Einar M. Sigurdsson, Laura Morelli, Rashmi Kumar, Eduardo M. Castaño and Blas Frangione covering the research area of Molecular Biology, Physiology and Oncology. It is primarily cited by scholars working on Physiology (565 citations), Molecular Biology (425 citations) and Biomaterials (184 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm0798-822.